Neurological Diseases: From Molecular Basis to Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 1246
Special Issue Editor
Interests: molecular biology; neurogenetics; motor neuron diseases; amyotrophic lateral sclerosis; gene variants; gene regulation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurological diseases represent a complex and challenging spectrum of disorders that affect the central and peripheral nervous systems, including the brain, spinal cord, and peripheral nerves. They include a variety of conditions such as neurodegenerative, neurovascular, neuro-oncological, neuroinflammatory, and infectious diseases, as well as traumatic brain and spinal cord injuries.
Neurological disorders can severely affect a person's quality of life, causing physical, emotional, and cognitive impairment. Managing neurological conditions often requires specialized care and complicated treatment options. In addition, the complexity of these conditions makes diagnosis and treatment difficult. This can lead to misdiagnosis and delayed treatment, which can worsen symptoms and increase the burden on patients and caregivers. The World Health Organization (WHO) has reported an increase in neurological diseases, due in part to an ageing population and the lack of definitive therapies, with a major impact on the sustainability of health and social systems, and a large number of people with disabilities, with serious economic and social consequences for their families. Developing effective treatments for neurological disorders is critical to alleviating symptoms, improving patient outcomes, and enhancing overall quality of life. Despite advances in medical science, many neurological disorders remain incurable or inadequately treated. Therefore, new scientific and epidemiological evidence is needed to develop innovative therapies and interventions.
The aim of this Special Issue is to focus on advances in research into neurological disorders, from understanding the causes and mechanisms of disease, to identifying new therapeutic targets, developing methods for early diagnosis and screening of individuals at risk, and developing new therapies and preventive strategies to improve the management and quality of life of neurological patients. Various disciplines including biology, genetics, pharmacology, neurology, neurosurgery, and related fields are involved in this research.
We encourage the submission of research articles, reviews, and perspectives on all relevant topics.
Dr. Claudia Ricci
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurological diseases
- pathogenesis
- therapy
- personalized medicine
- early diagnosis
- genetics
- neurology
- pharmacology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
